Abstract
Rationale
Sweet-substance-induced analgesia has been widely studied, and the investigation of the neurotransmitters involved in this antinociceptive process is an important way for understanding the involvement of the neural system controlling this kind of antinociception.
Objective
The aim of this study was to investigate the involvement of opioid and monoaminergic systems in sweet-substance-induced analgesia.
Methods
The present work was carried out in an animal model with the aim of investigating whether acute (24 h) or chronic (14 days) intake of a sweet substance, such as sucrose (250 g/l), is followed by antinociception. Tail withdrawal latencies in the tail-flick test were measured before and immediately after this treatment. Immediately after the recording of baseline values, independent groups of rats were submitted to sucrose or tap-water intake and, after chronic treatment, they were pretreated with intraperitoneal administration of (1) naltrexone at 0.5, 1, 2 or 3 mg/kg; (2) naloxonazine at 5, 10, 20 or 30 mg/kg; (3) methysergide at 0.5, 1, 2 or 3 mg/kg; (4) ketanserin at 0.5, 1, 2 or 3 mg/kg; or (5) physiological saline.
Results
Naltrexone and methysergide at two major doses decreased sweet-substance-induced analgesia after chronic intake of a sweet substance. These effects were corroborated by peripheral administration of naloxonazine and ketanserin.
Conclusions
These data give further evidence for: (a) the involvement of endogenous opioids and a μ1-opioid receptor in the sweet-substance-induced antinociception; (b) the involvement of monoamines and 5HT2A serotonergic/α1-noradrenergic receptors in the central regulation of the sweet-substance-produced analgesia.
Similar content being viewed by others
References
Abad F, Diaz NM, Domenech E, Robayna M, Rico J (1996) Oral sweet solution reduces pain-related behavior in preterm infants. Acta Paediatr 85:854–858
Anseloni VCZ, Weng H-R, Terayama R, Letizia D, Davis BJ, Ren K, Dubner R, Ennis M (2002) Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models. Pain 97:93–103
Bergmann F, Lieblich I, Cohen E, Ganchrow JR (1985) Influence of intake of sweet solutions on the analgesic effect of a low dose of morphine in randomly bred rats. Behav Neural Biol 44:347–353
Blass EM, Fitzgerald E (1988) Milk-induced analgesia and comforting in 10-day-old rats: opioid mediation. Pharmacol Biochem Behav 29:9–13
Blass EM, Hoffmeyer LB (1991) Sucrose as an analgesic for newborn infants. Pedriatics 87:215–218
Blass EM, Shide DJ (1994) Some comparisons among the calming and pain-relieving effects of sucrose, glucose, fructose and lactose in infant rats. Chem Senses 19:239–249
Blass EM, Fitzgerald E, Kehoe P (1987) Interactions between sucrose, pain and isolation distress. Pharmacol Biochem Behav 26:483–489
Borelli KG, Nobre MJ, Brandão ML, Coimbra NC (2004) Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of dorsolateral and lateral columns of the periaqueductal gray matter. Pharmacol Biochem Behav 77:557–566
Coimbra NC, Brandão ML (1997) Effect of 5-HT2 receptor blockade on fear-induced analgesia elicited by electrical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray. Behav Brain Res 87:97–103
Coimbra NC, Tomaz C, Brandão ML (1992) Evidence for the involvement of serotonin in the antinociception induced by electrical or chemical stimulation of the mesencephalic tectum. Behav Brain Res 50:77–83
D’Anci KE, Kanarek RB, Marks-Kaufman R (1997) Beyond sweet taste: saccharin, sucrose, and polycose differ in their effects upon morphine-induced analgesia. Pharmacol Biochem Behav 56:341–345
Davis WM, Miya TS, Edwards LD (1956) The influence of glucose and insulin pretreatment upon morphine analgesia in the rat. J Am Pharm Assoc 45:60–62
Eichenberger GCD, Ribeiro SJ, Osaki MY, Maruoka RY, Resende GCC, Castellan-Baldan L, Corrêa SAL, DaSilva LA, Coimbra NC (2002) Neuroanatomical and psychopharmacological evidence for interaction between opioid and GABAergic neural pathways in the modulation of fear and defense elicited by electrical and chemical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray matter. Neuropharmacology 42:48–59
Gamaro GD, Manoli LP, Torres IL, Silveira R, Dalmaz C (2003) Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem Int 42:107–114
Hahn EF, Pasternak GW (1982) Naloxonazine, a potent, long-lasting inhibitor of opiate binding-sites. Life Sci 31:1385–1388
Haouari N, Wood C, Griffiths G, Levene M (1995) The analgesic effect of sucrose in full term infants: a randomised controlled trial. Br J Med 310:1498–1500
Holder MD (1988) Responsivity to pain in rats changed by the ingestion of flavoured water. Behav Neural Biol 49:45–53
Irusta AEC, Savoldi M, Kishi R, Resende GCC, Freitas RL, Carvalho AD, Coimbra NC (2001) Psychopharmacological evidences for the involvement of muscarinic and nicotinic cholinergic receptors on sweet substance-induced analgesia in Rattus norvegicus. Neurosci Lett 305:115–118
Israilova M, Suzuki F, Tanaka T, Nagatomo T, Taniguchi T, Muramatsu I (2002) Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes. Pharmacology 65:69–73
Johnson N, Pasternak GW (1984) Binding of 3H-naloxonazine to rat brain membranes. Mol Pharmacol 26:477–483
Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y (1992) Streptozocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by delta and kappa-opioid agonists. Brain Res 571:199–203
Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y (1994a) Streptozocin-induced diabetes selectively reduces antinociception mediated by μ1-opioid receptors, but not that mediated by μ2-opioid receptors. Neurosci Lett 165:141–143
Kamei J, Ohsawa M, Misawa M, Nagase H, Kasuya Y (1994b) Effects of diabetes on the morphine-induced Straub tail reaction in mice. Neurosci Lett 178:66–68
Kanarek RB, Mandillo S, Wiar C (2001) Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats. Brain Res 920:97–105
Klein SP, Green KF (1988) Tolerance to morphine analgesia from brief exposure to a palatable solution. Brain Res Bull 21:963–965
Ko MCH, Naughton NN, Traynor JR, Song MS, Woods JH, Rice KC, McKnight AT (2002) Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors. Br J Pharmacol 135:943–950
Lapiz MD, Fulford A, Muchimapura S, Mason R, Parker T, Marsden CA (2003) Influence of post weaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci Behav Physiol 33:13–19
Lieblich I, Cohen E, Blass EM, Bergmann F (1983) Morphine tolerance in genetically selected rats induced by chronically elevated saccharine intake. Science 221:871–873
Ling GSF, Simantov R, Clark JA, Pasternak GW (1986) Naloxonazine actions in vivo. Eur J Pharmacol 129:33–38
Matsumoto K, Nomura H, Murakami Y, Taki K, Takahata H, Watanabe H (2003) Long-term social isolation enhances picrotoxin seizure susceptibility in mice: up-regulatory role of endogenous brain allopregnanolone in GABAergic systems. Pharmacol Biochem Behav 75:831–835
Mercer ME, Holder MD (1996) Antinociceptive effects of palatable sweet ingesta on human responsivity to pressure pain. Physiol Behav 61:311–318
Nichols DS, Thorn BE, Berston GG (1989) Opiate and serotonergic mechanisms of stimulation-produced analgesia within the periaqueductal gray. Brain Res Bull 22:717–724
Nishimura SL, Recht LD, Pasternak GW (1984) Biochemical characterization of high affinity 3H-opioid binding: further evidence for mu1 sites. Mol Pharmacol 25:29–37
Osaki MY, Castellan-Baldan L, Calvo F, Carvalho AD, Felippotti TT, de Oliveira R, Ubiali WA, Paschoalin-Maurin T, Elias-Filho DH, Motta V, da Silva LA, Coimbra NC (2003) Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of μ1- and κ-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus. Brain Res 992:179–192
Prado WA, Roberts MHT (1985) An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain. Brain Res 340:219–228
Roane DS, Martin RJ (1990) Continuous sucrose feeding decreases pain threshold and increases morphine potency. Pharmacol Biochem Behav 35:225–229
Segato FN, Castro-Souza C, Segato EM, Morato S, Coimbra NC (1997) Sucrose ingestion causes opioid analgesia. Braz J Med Biol Res 30:981–984
Skogsdal Y, Eriksson M, Schollin J (1997) Analgesia in newborns given oral glucose. Acta Paediatrica 86:217–220
Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat: cell bodies and terminals. Neurosci 6:557–618
Takeshita N, Yamaguchi I (1995) Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice. Br J Pharmacol 116:3133–3138
Takeshita N, Ohkubo Y, Yamaguchi I (1995) Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism. J Pharmacol Exp Ther 275:23–30
Wolozin BL, Pasternak GW (1981) Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci USA 78:6181–6185
Acknowledgements
This work was sponsored by FAPESP (proc. 95/3604-4, 02/01496-5, 02/03705-0 and 03/12882-6) and FAEPA (proc. 537/95 and 355/2000). E.N. Segato, R. Kishi and R.L. de Freitas were recipients of scholarships from FAPESP (proc. 98/07416-6, 00/02204-2 and 01/03752-6, respectively). E.C.C. Rebouças is the recipient of a Master fellowship from SAEB. R.L. de Freitas is the recipient of a Master fellowship from FAPESP (03/05256-1). N.C. Coimbra is the recipient of a research fellowship from CNPq (proc. 300772/97-1). The authors are grateful to Valdir Mazzucato Jr. and Daoud Hibrahim Elias Filho for expert technical assistance. D.H. Elias-Filho is the recipient of a scholarship from FAPESP (TT2, proc. 02/01497-1). We thank Prof. L.M.L. Caliri Juzzo and Dr. Constance Oliver for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rebouças, E.C.C., Segato, E.N., Kishi, R. et al. Effect of the blockade of μ1-opioid and 5HT2A-serotonergic/α1-noradrenergic receptors on sweet-substance-induced analgesia. Psychopharmacology 179, 349–355 (2005). https://doi.org/10.1007/s00213-004-2045-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-2045-x